Division of Gastroenterology & Hepatology Research

Our research goals at NYU Langone’s Division of Gastroenterology and Hepatology are to provide access to the latest treatments in the pipeline to our patients and to advance knowledge of gastroenterology and hepatology through innovative basic science, translational research, and clinical trials. We aim to foster a spirit of scientific inquiry and innovation among faculty, fellows, and students.
Our researchers study the biology, prevention, diagnosis, and treatment of gastrointestinal (GI) and liver diseases. Among our current areas of research are the following:
- role of the gut microbiome in health and the pathogenesis of disease such as colorectal cancer, liver cancer, and fatty liver and other diseases
- role of GI infection and gut microbial dysbiosis in the pathogenesis of inflammatory bowel disease
- quality and innovations in enhanced technologies for colon cancer screening
- bariatric endoscopy outcomes in obesity and fatty liver disease
- clinical trials in all areas of liver disease, inflammatory bowel disease, colorectal cancer screening and prevention, and other GI conditions
- cirrhosis and hepatitis C infection
Select Faculty Publications
Esophageal Disorders in the Older Adult
Current treatment options in gastroenterology. 2025 Dec ; 23:
Editorial: Resecting Assumptions-Do Proctocolectomy Guidelines Hold Up? [Editorial]
Alimentary pharmacology & therapeutics. 2025 Aug 22;
A Just Appraisal: Co-creating a New Health Equity Framework with Learners through Journal Club to Evaluate the Literature
Journal of general internal medicine. 2025 Aug 04;
Evaluating Hospital Course Summarization by an Electronic Health Record-Based Large Language Model
JAMA network open. 2025 Aug 01; 8:e2526339
Scoping the future: what endoscopists really think about artificial intelligence [Editorial]
Gastrointestinal endoscopy. 2025 Aug ; 102:170-171
Evaluation of Patients with Liver Disease before Nonhepatic Surgery
Clinics in liver disease. 2025 Aug ; 29:563-582
The Liver in Systemic Disease [Editorial]
Clinics in liver disease. 2025 Aug ; 29:xiii-xv
Cost-Effectiveness of Endoscopic Stricturotomy Versus Resection Surgery for Crohn's Disease Strictures
Healthcare (Basel, Switzerland). 2025 Jul 24; 13: